United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$21Mraised across 2 rounds since 2023, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Jefferson Life SciencesLead
National Institutes of Health
Surge
New York VenturesReported by Jefferson Life Sciences and 1 other
From Fesarius Therapeutics's own website: 1 founder, 4 on the team.
AdvisersDr. Jason Spector
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Fesarius Therapeutics's investors include National Institutes of Health, New York Ventures, Jefferson Life Sciences, Surge and Johnson & Johnson Robotics and Digital Solutions, and 2 more on record. Jefferson Life Sciences led its latest round.
Fesarius Therapeutics has raised $21M across 2 rounds since 2023.
Fesarius Therapeutics's most recent round was a Series A of $20M in Jun 2026, led by Jefferson Life Sciences.
Its most recent round, $20M in Jun 2026, is also its largest on record.
Fesarius Therapeutics's first round on record, in Aug 2023, was backed by National Institutes of Health and New York Ventures.
Fesarius Therapeutics's latest named round is a Series A, in Jun 2026.
Fesarius Therapeutics is based in the United States.
Jefferson Life Sciences led the Series A in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
